Citadel Advisors’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,674
| Closed | -$64.5K | – | 7224 |
|
|
2024
Q4 | $64.5K | Buy |
6,674
+3,013
| +82% | +$29.1K | ﹤0.01% | 5381 |
|
|
2024
Q3 | $68.1K | Sell |
3,661
-1,003
| -22% | -$18.7K | ﹤0.01% | 5040 |
|
|
2024
Q2 | $77.6K | Sell |
4,664
-1,693
| -27% | -$28.2K | ﹤0.01% | 5042 |
|
|
2024
Q1 | $110K | Sell |
6,357
-4,072
| -39% | -$70.7K | ﹤0.01% | 5038 |
|
|
2023
Q4 | $163K | Buy |
+10,429
| New | +$163K | ﹤0.01% | 4698 |
|
|
2023
Q3 | – | Sell |
-11,155
| Closed | -$872K | – | 6642 |
|
|
2023
Q2 | $872K | Buy |
11,155
+8,820
| +378% | +$690K | ﹤0.01% | 3121 |
|
|
2023
Q1 | $212K | Sell |
2,335
-1,047
| -31% | -$94.9K | ﹤0.01% | 4580 |
|
|
2022
Q4 | $399K | Buy |
+3,382
| New | +$399K | ﹤0.01% | 4080 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6856 |
|
|
2022
Q2 | – | Sell |
-4,737
| Closed | -$736K | – | 7063 |
|
|
2022
Q1 | $736K | Buy |
4,737
+2,123
| +81% | +$330K | ﹤0.01% | 4038 |
|
|
2021
Q4 | $778K | Buy |
+2,614
| New | +$778K | ﹤0.01% | 4122 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7232 |
|
|
2020
Q4 | – | Sell |
-1,674
| Closed | -$1.06M | – | 5696 |
|
|
2020
Q3 | $1.06M | Buy |
+1,674
| New | +$1.06M | ﹤0.01% | 2869 |
|